发明名称 Antigen binding constructs
摘要 The present invention is directed to antigen binding constructs comprising one or two epitope binding domains separated by a single chain Fc region of an antibody, wherein each epitope binding domain in capable of binding to VEGF, to dimers comprising two antigen binding constructs of the invention, pharmaceutical compositions comprising said dimers and their use in the treatment of diseases associated with VEGF signalling, such as diabetic macular edema (DME), wet age-related macular degeneration (Wet AMD), diabetic retinopathy, retinal vein occlusion (RVO), and corneal neovascularization, and polynucleotide sequences encoding said antigen binding constructs.
申请公布号 US9499612(B2) 申请公布日期 2016.11.22
申请号 US201214235330 申请日期 2012.07.25
申请人 Glaxo Group Limited 发明人 Ashman Claire;Catchpole Ian Richard;Hughes-Thomas Zoe;Lewis Alan Peter;Steward Michael
分类号 C12P21/08;C07K16/00;C07K16/22;A61K39/00 主分类号 C12P21/08
代理机构 代理人 Octavio Leah M.;Lockenour Andrea V.
主权项 1. An antigen binding construct comprising two immunoglobulin single variable domains separated by a single heavy chain constant region of an IgG or IgA antibody comprising one or more CH1, CH2, and CH3 constant region antibody domains, wherein each immunoglobulin single variable domain is capable of binding to VEGF and further wherein the first immunoglobulin single variable domain is attached to the N-terminus of the single heavy chain constant region and comprises the CDR sequences of SEQ ID NOs: 114, 115, and 116, and the second immunoglobulin single variable domain is attached to the C-terminus of the single heavy chain constant region and comprises the CDR sequences of SEQ ID NOs: 117, 118, and 119.
地址 Brentford, Middlesex GB